FDA Clears IND Application and Grants Orphan Drug Designation to an Experimental Therapy for Progressive Multifocal Leukoencephalopathy
source: pixabay.com

FDA Clears IND Application and Grants Orphan Drug Designation to an Experimental Therapy for Progressive Multifocal Leukoencephalopathy

According to a story from PR Newswire, the cell therapy company Cellevolve Bio, Inc., recently announced that the US Food and Drug Administration (FDA) has advanced the development of its…

Continue Reading FDA Clears IND Application and Grants Orphan Drug Designation to an Experimental Therapy for Progressive Multifocal Leukoencephalopathy